Please assess the completion status of the following clinical trial:

Trial Title: Personalized Versus Standard Hydration for Prevention of CI-AKI: a Randomized Trial With Bioimpedance Analysis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* consecutive patients admitted in Cardiology Unit for coronary or peripheral angiography with lower fluid status defined on the basis bio-impedance analysis (Male with resistance/height ratio \> 315 Ohm/meter and Female \> 380 Ohm/meter).~Exclusion Criteria:~* contrast medium administration within the 10 days~* end stage renal failure requiring dialysis~* refused to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Standard saline infusion (Type: ACTIVE_COMPARATOR): All patients received standard intravenous saline hydration (0.9% sodium chloride, 1 ml/kg/h for 12 hours before and after procedure)
- Double saline infusion (Type: EXPERIMENTAL): All patients received double dose of intravenous saline hydration (0.9% sodium chloride, 2 ml/kg/h for 12 hours before and after procedure)

Based on this trial design, predict the completion outcome and termination type (if applicable).